Guy Young/LinkedIn;
Mark T. Reding/emedevents.com/
Mar 12, 2026, 11:50
Guy Young: Clinical Conversations on Gene Therapy Progress in Hemophilia B at THSNA 2026
Guy Young, Director of the Hemostasis and Thrombosis Center at Children’s Hospital Los Angeles, shared a post on LinkedIn:
“I’m looking forward to speaking at THSNA 2026 on Driving Innovation Forward in Hemophilia B With Gene Therapy: Clinical Conversations on Progress and Guidance on Practical Delivery.
Join Mark T. Reding, MD and I as we discuss:
- Clarifying the role of gene therapy in hemophilia B within an evolving treatment landscape
- Improving patient selection and counseling in real-world practice
- Operationalizing delivery – from referral coordination to infusion management, monitoring, and long-term follow-up across care settings
This symposium will take place live in person on March 21 at 6:45 AM PDT at the Oregon Convention Center in Portland during the THSNA 2026 Annual Meeting, with a live virtual program to follow on March 30 at 7:00 PM EDT.
Other posts featuring Guy Young on Hemostasis Today.
-
Nov 8, 2026, 19:31Anna Kajaste-Rudnitski: Presenting AAV-Induced p53 Signalling in Human CNS Cells at ESGCT 26
-
Nov 8, 2026, 19:29David McIntosh: Cybersecurity Matters, but Blood Availability Remains the Bigger Challenge
-
Nov 8, 2026, 19:26Wenxue Ma: An Integrative Framework for Macrophage-Mediated Therapeutic Resistance in Cancer
-
Nov 8, 2026, 19:25Yildiz Yigit: Presenting a Polycythemia Vera Case at the MPN Subcommittee Session
-
Nov 8, 2026, 18:56Denis Oduor: Strengthening the Regulation and Delivery of Blood Transfusion and Transplantation Services
-
Nov 8, 2026, 18:28Raghavendra Rao: A Narrative Review on Chronic Venous Disease during Pregnancy
-
Nov 8, 2026, 17:57Dhiren Patel: PLD1-Derived Phospholipids Regulate NAD Kinase and ROS Production in Neutrophils
-
Nov 8, 2026, 17:48Andra T.: What Causes Antiphospholipid Syndrome? – Four Steps, not One Cause
-
Nov 8, 2026, 17:38Nasrin Samadi: Can a Normal Clotting Test Be Misleading?